Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Haanen

Showing results (141-150 of 161) with videos related to

Pageof 17
Sort By:
Blood|March 1, 1989
Alternating v repeated postremission treatment in adult acute myelogenous leukemia: a randomized phase III study (AML6) of the EORTC Leukemia Cooperative GroupR Zittoun, U Jehn, D Fière, et al.
Haematology and Blood Transfusion|January 1, 1990
A randomized comparison of intensive maintenance treatment for adult acute myelogenous leukemia using either cyclic alternating drugs or repeated courses of the induction-type chemotherapy: AML-6 trial of the EORTC Leukemia Cooperative GroupU Jehn, R Zittoun, S Suciu, et al.
The Journal of Rheumatology|January 1, 1991
Controlled trial of hypnotherapy in the treatment of refractory fibromyalgiaH C Haanen, H T Hoenderdos, L K van Romunde, et al.
Blood|May 1, 1986
Depletion of donor lymphocytes by counterflow centrifugation successfully prevents acute graft-versus-host disease in matched allogeneic marrow transplantationT de Witte, J Hoogenhout, B de Pauw, et al.
Blood|August 15, 1989
Autologous transplantation of bone marrow purged in vitro with anti-CD7-(WT1-) ricin A immunotoxin in T-cell lymphoblastic leukemia and lymphomaF W Preijers, T De Witte, J M Wessels, et al.
Behring Institute Mitteilungen|August 1, 1988
GM-CSF enhances sensitivity of leukemic clonogenic cells to long-term low dose cytosine arabinoside with sparing of the normal clonogenic cellsT De Witte, P Muus, C Haanen, et al.
Cancer|August 1, 1986
A randomized comparison of maintenance treatment with androgens, immunotherapy, and chemotherapy in adult acute myelogenous leukemia. A Leukemia-Lymphoma Group Trial of the EORTCM Hayat, U Jehn, R Willemze, et al.
European Journal of Cancer & Clinical Oncology|April 1, 1988
In vivo cellular adriamycin concentrations related to growth inhibition of normal and leukemic human bone marrow cellsP A Speth, R A Raijmakers, J B Boezeman, et al.
Scandinavian Journal of Immunology|August 1, 1988
Human T lymphocyte differentiation antigens as target for immunotoxins or complement-mediated cytotoxicityF W Preijers, T De Witte, G P Rijke-Schilder, et al.
Blood|September 1, 1982
Adolescent and adult acute lymphoblastic leukemia: prognostic features and outcome of therapy. A study of 293 patientsM Baccarani, G Corbelli, S Amadori, et al.
Pageof 17

Showing results (141-150 of 161) with videos related to

Sort By:
Pageof 17
Blood|March 1, 1989
Alternating v repeated postremission treatment in adult acute myelogenous leukemia: a randomized phase III study (AML6) of the EORTC Leukemia Cooperative GroupR Zittoun, U Jehn, D Fière, et al.
Haematology and Blood Transfusion|January 1, 1990
A randomized comparison of intensive maintenance treatment for adult acute myelogenous leukemia using either cyclic alternating drugs or repeated courses of the induction-type chemotherapy: AML-6 trial of the EORTC Leukemia Cooperative GroupU Jehn, R Zittoun, S Suciu, et al.
The Journal of Rheumatology|January 1, 1991
Controlled trial of hypnotherapy in the treatment of refractory fibromyalgiaH C Haanen, H T Hoenderdos, L K van Romunde, et al.
Blood|May 1, 1986
Depletion of donor lymphocytes by counterflow centrifugation successfully prevents acute graft-versus-host disease in matched allogeneic marrow transplantationT de Witte, J Hoogenhout, B de Pauw, et al.
Blood|August 15, 1989
Autologous transplantation of bone marrow purged in vitro with anti-CD7-(WT1-) ricin A immunotoxin in T-cell lymphoblastic leukemia and lymphomaF W Preijers, T De Witte, J M Wessels, et al.
Behring Institute Mitteilungen|August 1, 1988
GM-CSF enhances sensitivity of leukemic clonogenic cells to long-term low dose cytosine arabinoside with sparing of the normal clonogenic cellsT De Witte, P Muus, C Haanen, et al.
Cancer|August 1, 1986
A randomized comparison of maintenance treatment with androgens, immunotherapy, and chemotherapy in adult acute myelogenous leukemia. A Leukemia-Lymphoma Group Trial of the EORTCM Hayat, U Jehn, R Willemze, et al.
European Journal of Cancer & Clinical Oncology|April 1, 1988
In vivo cellular adriamycin concentrations related to growth inhibition of normal and leukemic human bone marrow cellsP A Speth, R A Raijmakers, J B Boezeman, et al.
Scandinavian Journal of Immunology|August 1, 1988
Human T lymphocyte differentiation antigens as target for immunotoxins or complement-mediated cytotoxicityF W Preijers, T De Witte, G P Rijke-Schilder, et al.
Blood|September 1, 1982
Adolescent and adult acute lymphoblastic leukemia: prognostic features and outcome of therapy. A study of 293 patientsM Baccarani, G Corbelli, S Amadori, et al.
Pageof 17